Naringenin (NG) is a flavanone abundant in grapefruit and other citrus fruits that presents several pharmacological effects, such as antioxidant, antiinflammatory, analgesic, among others. We investigated the antinociception of systemic administration of naringenin (NG) and some of the mechanisms of action underlying its effect. Intraperitoneal administration of NG (10 mg/kg) inhibited the mechanical allodynia induced by partial sciatic nerve ligation (PSNL) and carrageenan in 65 ± 4 and 43 ± 9% (2 h), respectively. NG also reduced the writhes number (30 mg/kg: 90 ± 9%) and the nociceptive response of formalin (100 mg/kg: 75 ± 12%, inflammatory phase), bradykinin (30 mg/kg: 79 ± 6%) and prostaglandin E 2 (100 mg/kg: 98 ± 1%). Besides, NG reduced the glutamate-induced nociception with ID50 value of 66 mg/kg, effect that was reversed by naloxone. NG, at antinociceptive doses, did not affect the locomotor activity. Our findings demonstrated that systemic NG exerts anti-allodynic activity in neuropathic pain model and antinociceptive effect in several chemical and inflammatory models of nociception, with participation of glutamatergic and opioid system.
Naringenin (NG, 4′,5,7-trihydroxyflavanone) is a flavanone, a class of flavonoids greatly found in citrus fruits, which presents several pharmacological effects, such as antitumor, antioxidant, and antiinflammatory, among others [1, 2, 3] . Furthermore, it was reported the analgesic properties of NG on neuropathic pain models presenting attenuation of mechanical allodynia and thermal hyperalgesia with inhibition of inflammatory mediators expression and glial cells activation [4] . NG also exerted protection against hyperalgesia and allodynia in experimental diabetic neuropathy [5] . Recently, Pinho-Ribeiro et al. [6] showed that NG inhibited both inflammatory pain and neurogenic inflammation when administered by oral route. Here, we investigated the effects of systemic administration of NG in experimental models of nociception and added further mechanisms involved in its antinociception.
Previous studies demonstrated the analgesics effects of NG in neuropathic pain induced by spinal nerve ligation and chronic constriction injury [4, 7] . We showed that single treatment of animals with NG (10 mg/kg, i.p.) reduced the mechanical allodynia response induced by another type of neuropathic pain model, PSNL, with inhibition of 62 ± 8 and 65 ± 4% at 1 and 2 h, respectively ( Figure 1A ). When NG (10 mg/kg, i.p.) was repeatedly administered for 7 days, the treatment reduced the mechanical allodynia and the suspension of treatment for 4 days, for tolerance exclusion, did not alter the anti-allodynic effect of NG ( Figure 1B ). Hu & Zhao [4] observed a decreased in the TNF- and IL-1 expression by NG after neuropathic pain induced by spinal nerve ligation. Besides neuropathic pain, these mediators are also involved on the carrageenan-induced local inflammation [8] . It was observed that NG (10-100 mg/kg, i.p.) did not alter the paw edema formation induced by carrageenan measured during 4 h ( Figure 1C ) but NG (10 and 100 mg/kg, i.p.) reduced the carrageenan-induced mechanical allodynia at 0.5, 1 and 2 h after treatment (inhibition at 2 h by 43 ± 9 and 43 ± 4%, respectively) ( Figure 1D ). NG at dose of 30 mg/kg, i.p., decreased the allodynia response at 1 and 2 h after treatment with inhibition of 45 ± 10% at 2 h ( Figure 1D ). Including, Pinho-Ribeiro et al. [6] demonstrated that the oral treatment of animals with NG inhibited the mechanical hyperalgesia induced by carrageenan as well as the production of pro-inflammatory cytokines (IL-33, TNF- and IL-1).
Intraperitoneal injection of NG (1-100 mg/kg) promoted antinociception effect against acetic acid, formalin (the inflammatory phase), bradykinin and prostaglandin E 2 ( Table 1 ). In accordance with our results, oral treatment with NG also reduced PGE 2 -induced mechanical hyperalgesia [6] . It is well established that glutamate is an important excitatory neurotransmitter and release inflammatory mediators and neuropeptides in the nociceptive signals transmission [9] . Our results revealed that NG reduced the nociceptive behavior induced by glutamate with ID50 value of 66.0 (42.6-102.4) mg/kg and inhibition of 59 ± 6% at dose of 100 mg/kg. Notably, the pre-treatment of animals with naloxone (1 mg/kg, i.p.) reversed the antinociception promoted by NG (66 mg/kg, i.p.), suggesting a participation of opioid system.
In addition, the release of glutamate and peptide transmitters by presynaptic terminal of the nociceptor is modulated by TRP channels, including TRPV1 and TRPA1 [10] . Interestingly, they also have important role in inflammatory and neuropathic pain [11] , however, NG (10-100 mg/kg, i.p.) did not reduce the nociceptive response induced by capsaicin or cinnamaldehyde (TRPV1 and TRPA1 receptor agonists, respectively) (data not shown). Indeed, NG did not inhibit the first phase of formalin-induced nociception, in which TRPA1 is also involved [12] . In accordance with our data, Straub et al. [13] demonstrated that NG did not block TRPA1 and had partial inhibition of TRPV1 at very high concentrations in vitro, but blocked TRPM3. Finally, the antinociceptive doses of NG did not affect the locomotor activity in the rota-rod test (data not shown).
Altogether, we showed the systemic antinociceptive properties of NG and these effects are related to inhibition of inflammatory mediators release. In addition, we demonstrated for the first time that the modulation of glutamatergic and opioid system is also involved in NG antinociception.
Experimental
Drugs and reagents: Bradykinin, capsaicin, cinnamaldehyde, ʟglutamic acid hydrochloride, naringenin (purity grade  95%) and prostaglandin E 2 were obtained from Sigma-Aldrich (St Louis, MO). Morphine sulphate (Dimorf®) was kindly provided by Cristália (São Paulo, SP). All other chemicals (analytical grade) were purchased from standard commercial suppliers. All drugs were immediately dissolved in 0.9% NaCl solution before administration.
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Natural Product Communications Vol. 12 (9) 2017 1445 Animals: All the experiments were performed using female Swiss mice (25-35 g), housed at standard conditions of temperature (22 ± 2°C) under a 12/12 h light/dark cycle and with food and water ad libitum. The protocols were analyzed and approved by the Ethics Committee for the Animal Use from Biological Sciences Sector of Federal University of Paraná (CEUA/BIO -UFPR, approval number 705) and were in accordance with the ethical guidelines for investigations of experimental pain in conscious animals [14] .
Mechanical allodynia induced by PSNL:
The procedure to partial ligation of the sciatic nerve and evaluation of the mechanical allodynia response was described in Baggio et al. [15] . In sham group, the sciatic nerve was exposed without ligation and the animals received only saline (10 mL/kg, i.p.). The operated mice were treated with vehicle (saline, 10 mL/kg, i.p.) and NG (10 mg/kg, i.p.), 7 days after surgery.
The mechanical allodynia response was recorded before surgery (basal, B) and after treatment (0.5, 1, 2, 3 and 4 h) to evaluate the time-course effect of NG. In another set of experiments, the response of long-term treatment with NG (10 mg/kg, i.p., once a day) was evaluated during 14 days at 1 h after treatment. The treatment was performed from the 7th to the 13th day after nerve ligation, interrupted for 4 days and then re-initiated to assess the development of possible NG tolerance. Mechanical allodynia was measured as the withdrawal response frequency to 10 applications of 0.6 g of von Frey hairs (Stoelting, Chicago, USA).
Paw edema and mechanical allodynia induced by carrageenan:
Mice were intraperitoneally treated with vehicle (saline, 10 mL/kg) or NG (10-100 mg/kg) 30 min before intraplantar (i.pl.) injection of carrageenan (300 µg/paw, 20 µL). The paw thickness was measured using a digital micrometer (MT-045B Shanghai Metal Great Tools Co., Shanghai, China) before the induction of edema (B: basal) and at different time points after the injection of the phlogistic agent and the results were expressed in mm. The mechanical allodynia response was measured as cited above, before and after the injection of carrageenan [16] .
Abdominal constriction induced by acetic acid:
Animals were intraperitoneally pre-treated with vehicle (saline, 10 mL/kg) or NG (1, 3, 10 and 30 mg/kg), 30 min before the intraperitoneal (i.p.) injection of 0.6% acetic acid (0.45 mL/mouse). The abdominal constrictions were cumulatively counted over a period of 20 min [17] .
Nociception induced by formalin:
Briefly, the mice were treated with vehicle (saline, 10 mL/kg) or NG (10-100 mg/kg) by i.p. route and 30 min after the animals received i.pl. 20 µL of a 2.5% formalin solution (0.92% formaldehyde, in saline) under the ventral surface of the right hindpaw (intraplantar,). After that, the mice were observed from 0 to 5 min (neurogenic phase) and from 15 to 30 min (inflammatory phase) and the time that they spent licking the injected paw was considered as indicative of nociception [17] .
Nociception induced by bradykinin, prostaglandin E 2 or glutamate: NG (3-100 mg/kg, i.p.) or vehicle (saline, 10 mL/kg, i.p.) was administered to mice 30 min before i.pl. injection of 20 µL of bradykinin (3 nmol/paw), prostaglandin E 2 (30 nmol/paw) or glutamate (20 µmol/paw in isotonic saline solution, with pH adjusted to 7.4). After that, the animals were observed individually for 15 min, and the amount of time spent licking the injected paw was considered as indicative of nociceptive behavior [15, 18] .
Involvement of opioid system:
In order to evaluate the opioid system in the NG antinociception, mice were pre-treated with naloxone (1 mg/kg, i.p., a non-selective opioid receptor antagonist), 30 min before the administration of vehicle (saline, 10 mL/kg, i.p.), morphine (1 mg/kg, s.c.) or NG (66 mg/kg, i.p.). In other group of mice, vehicle was administered 30 min before NG, morphine or vehicle [17] . Thirty minutes later, the animals received an i.pl. glutamate injection (20 µmol/paw, 20 µL). The nociceptive response was evaluated as previously mentioned.
Nociception induced by capsaicin and cinnamaldehyde:
The procedure used was previously described by Baggio et al. [19] . Mice were treated with vehicle (saline, 10 mL/kg, i.p.) or NG (10-100 mg/kg, i.p.), 30 min before i.pl. injection of 20 µL of capsaicin (5.2 nmol/paw) or cinnamaldehyde (100 nmol/paw). Then, the animals were observed for 5 min and the amount of time spent licking the injected paw was used as index of nociception.
Locomotor activity:
The rota-rod test was performed to investigate the possible nonspecific muscle-relaxant or sedative effects of NG. The detailed description of the apparatus was described previously [20] . Mice were pre-selected 24 h before to exclude the animals that did not remain on the bar for 2 consecutive periods of 60 s, with rotation at a constant speed of 17 rpm. After that, the animals were pre-treated by i.p. route with vehicle (saline, 10 mL/kg) and NG (30 mg/kg and 100 mg/kg) 30 min before the test. The results were expressed as time (s) of permanence on the rota-rod and the cut-off time used was 60 s.
Statistical analysis:
Data were presented as means ± standard error of the mean (S.E.M.). Comparisons between experimental and control groups were performed by one-way analysis of variance (ANOVA) followed by Newman Keul's test when appropriate. Statistical comparisons of edema and mechanical allodynia data were performed by two-way ANOVA, followed by Bonferroni's multi-comparison post hoc test. P values less than 0.05 were considered as indicative of significance. ID50 value (dose capable of inhibiting the nociceptive response by 50% relative to the control value) were determined by nonlinear regression analysis and reported as geometric mean. All the statistical analysis were performed using Graph-Pad software (GraphPad software, San Diego, CA, USA).
